Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected] Learn more

Active Wnt1-V5 Citations (2)

Originally described in: Disulfide Bond Requirements for Active Wnt Ligands.
MacDonald BT, Hien A, Zhang X, Iranloye O, Virshup DM, Waterman ML, He X J Biol Chem. 2014 May 19. pii: jbc.M114.575027.
PubMed Journal

Articles Citing Active Wnt1-V5

A molecular mechanism for Wnt ligand-specific signaling. Eubelen M, Bostaille N, Cabochette P, Gauquier A, Tebabi P, Dumitru AC, Koehler M, Gut P, Alsteens D, Stainier DYR, Garcia-Pino A, Vanhollebeke B. Science. 2018 Aug 17;361(6403). pii: science.aat1178. doi: 10.1126/science.aat1178. Epub 2018 Jul 19. PubMed
The FHP01 DDX3X Helicase Inhibitor Exerts Potent Anti-Tumor Activity In Vivo in Breast Cancer Pre-Clinical Models. Gherardini L, Inzalaco G, Imperatore F, D'Aurizio R, Franci L, Miragliotta V, Boccuto A, Calandro P, Andreini M, Tarditi A, Chiariello M. Cancers (Basel). 2021 Sep 27;13(19). pii: cancers13194830. doi: 10.3390/cancers13194830. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.